Background Inheritance patterns show familial clustering of gastrointestinal cancers, and multiple germline conditions have now been identified that predispose to colorectal, gastric …
P Peltomäki, M Nyström, JP Mecklin, TT Seppälä - Gastroenterology, 2023 - Elsevier
Lynch syndrome (LS) is one of the most prevalent hereditary cancer syndromes in humans and accounts for some 3% of unselected patients with colorectal or endometrial cancer and …
E Schamschula, M Kinzel, A Wernstedt, K Oberhuber… - Biomolecules, 2022 - mdpi.com
Simple Summary Colorectal cancer (CRC) in adolescents and young adults (AYA) is rare. Genetic causes include autosomal recessive and dominant monogenic disorders due to …
NC Helderman, KD Andini, ME van Leerdam… - The Journal of Molecular …, 2024 - Elsevier
Screening for Lynch syndrome (LS) in colorectal cancer (CRC) and endometrial cancer patients generally involves immunohistochemical staining of the mismatch repair (MMR) …
Infiltrating ductal adenocarcinoma of the pancreas, referred to here as “pancreatic cancer,” is one of the deadliest of all of the solid malignancies. The five-year survival rate in the United …
AS Van Der Werf, T Lam, D Terlouw… - …, 2023 - gastrojournal.org
Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome and is caused by pathogenic constitutional variants in 1 of the mismatch repair (MMR) genes …
M Devall, MW Ali, S Eaton, DJ Weisenberger… - Cancer …, 2023 - Wiley Online Library
Introduction Lynch syndrome (LS) is a hereditary condition that increases the risk of colorectal (CRC) and extracolonic cancers that exhibit microsatellite instability (MSI‐H). MSI …
A Dal Buono, A Puccini, G Franchellucci, M Airoldi… - Cancers, 2024 - mdpi.com
Simple Summary Lynch syndrome (LS) stands as the predominant inherited cancer condition at present. Currently, surveillance is based on genotype-driven strategies and …
BS Geurts, LJ Zeverijn… - The Journal of …, 2024 - Wiley Online Library
Abstract In the Drug Rediscovery Protocol (DRUP), patients with cancer are treated based on their tumor molecular profile with approved targeted and immunotherapies outside the …